Home › Categories › Corporate Reports› Management Commentary

Management Commentary.pdf

USANA Q1 2023 Management Commentary.pdf

🔗 Source: d1io3yog0oux5.cloudfront.net

📊 Size: 166 KB

👤 Author: Phil Carson

⬇️ Downloads: 98

Summary

USANA Health Sciences, Inc. reported Q1 2023 net sales of $248 million, a 9% sequential increase, and diluted EPS of $0.95, a 44% sequential increase. The company generated $13 million of operating cash flow and updated its fiscal 2023 net sales and diluted EPS guidance to $875-$950 million and $2.40-$3.30, respectively. Net sales were driven by increased demand in China and purchasing ahead of price increases, with active customer counts stabilizing. The company is prioritizing re-engagement with sales leaders through in-person meetings and events, and is preparing to launch a new market later this year.

Download File

Description

USANA Health Sciences, Inc. reported Q1 2023 net sales of $248 million, a 9% sequential increase, and diluted EPS of $0.95, a 44% sequential increase.

Technical Information

File Format: PDF
File Size: 166 KB
Pages: 9
Language: EN
Author: Phil Carson
Total Downloads: 98
Last Updated: 22 hours ago

Document Overview

This PDF document about Management Commentary provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Management Commentary.